Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma
Background: Secondary glaucoma is found in 18% to 38% of patients with uveitis, and is one of the most severe uveitic complications. The glaucomatous process is characterized by the progressive optic nerve neuropathy. The lack of efficacy of conventional neuroprotective approaches urged us to search...
Saved in:
Main Authors: | V. V. Savko (Author), V. V. Savko Jnr (Author) |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of phosphocreatine on ocular hemodynamics and functional status of the macula in patients with dry age-related macular degeneration
by: V.V. Savko Snr, et al.
Published: (2017) -
Update in treatment of uveitic macular edema
by: Koronis S, et al.
Published: (2019) -
Neuroprotective therapies for glaucoma
by: Song W, et al.
Published: (2015) -
Neuroprotection in Glaucoma: Old and New Promising Treatments
by: Dario Rusciano, et al.
Published: (2017) -
A case report of uveitis with ocular hypertension
by: N. V. Konovalova, et al.
Published: (2020)